Best At-Home Allergy Immunotherapy in 2026: Every Provider Compared

Quick Answer

Five companies now offer at-home sublingual immunotherapy in the US: Curex ($39–99/month), Wyndly ($99–110), Nectar ($99), Quello ($89), and HeyAllergy (from $47). All use compounded multi-allergen SLIT drops, all are off-label, and combined they've treated fewer than 100,000 patients against an addressable market of 100+ million Americans with allergic rhinitis. No single provider is best for everyone — insurance status, age, state, and allergen profile determine the right match.

Quick Facts

Detail	Info
Price range	Cheapest = HeyAllergy from $47/month; cheapest with insurance = Curex from $39/month; most expensive = Wyndly $110/month quarterly (2026)
Trustpilot ratings	Wyndly: 4.3/5 (22 reviews). Curex: 3.3/5 (19 reviews). Others: minimal reviews
Unique: Curex	Only provider billing insurance directly; ages 5+; partners with Allergychoices (50+ years)
Unique: Wyndly	90-day money-back guarantee; also prescribes FDA-approved SLIT tablets; all 50 states
Unique: Nectar	Strongest clinical advisory team; only vertically integrated (in-house pharmacy); $24M+ funded
NOT immunotherapy	Allermi ($45/mo) and Picnic ($12–20/mo) are symptom-management nasal sprays, not immunotherapy

"What's the Best At-Home Allergy Drop Service in 2026?"

You've decided you want immunotherapy — not another year of antihistamines. You want it at home, not in a clinic every week. You start searching and find five providers with similar-looking websites, similar pricing, and similar promises.

The marketing blurs together. Everyone claims board-certified physicians, custom formulations, and convenient home delivery. You can't tell which differences are real and which are branding.

Two things complicate the search further: Allermi and Picnic appear in results for "at-home allergy treatment" but are NOT immunotherapy — they're custom nasal spray subscriptions that manage symptoms without modifying your immune system. And all five actual immunotherapy providers use off-label compounded drops with fewer than 100,000 combined patients, in an industry that barely existed 5 years ago.

How They Actually Differ

Step 1 — Clinical models and pharmacy matter more than marketing. Nectar is the only provider manufacturing drops in-house (vertically integrated), with a clinical advisory board including Dr. Kari Nadeau (Harvard) and Dr. Mohamed Shamji (EAACI president). Curex partners with Allergychoices, the largest US SLIT compounding network (50+ years, 300,000+ patients). Wyndly was founded by Dr. Manan Shah, a board-certified ENT, and uniquely prescribes FDA-approved SLIT tablets alongside custom drops. HeyAllergy and Quello have less publicly documented clinical infrastructure.

Step 2 — Insurance changes the math entirely. Curex is the only provider billing insurance directly, reducing costs to $39/month for eligible patients versus $89–110 self-pay at competitors. Over a 3-year treatment course, that's a potential difference of $2,160+. Every other provider is self-pay only, making your insurance status the single largest variable in which provider is cheapest.

Step 3 — Trust signals vary significantly. Wyndly leads on consumer trust: 4.3/5 Trustpilot with 82% five-star reviews and a 90-day money-back guarantee. Curex has the most review volume but a lower 3.3/5 Trustpilot score with 53% one-star reviews and a BBB "C" rating with 54 complaints. 🚩 Curex has 2 FDA enforcement actions on record (2021, 2025). Nectar has $24M+ in funding but only 1 Trustpilot review. Quello and HeyAllergy have minimal public review data.

What To Do Next

1. Eliminate providers that don't serve you. Curex: 44 states, ages 5+. Wyndly: all 50 states. Nectar: ~44 states, adults 18+ only. Quello: ~21 states. HeyAllergy: check their site for current coverage. If you need pediatric treatment, only Curex qualifies among the major providers.

2. Run your insurance check. Call your insurer and ask about sublingual immunotherapy coverage (CPT 95180). If covered: Curex at $39/month is likely your cheapest option. If not: compare self-pay prices and weigh Wyndly's guarantee, Nectar's clinical team, or HeyAllergy's lower price point.

3. Take a free 3-minute allergy quiz. It identifies your specific allergens, verifies your state eligibility, and shows personalized pricing across providers. This is faster than calling five companies individually.

When Each Provider Wins

Choose Curex if: your insurance covers SLIT and you want the lowest monthly cost, or you need treatment for a child (ages 5+). Curex's Allergychoices partnership provides the most established compounding infrastructure.

Choose Wyndly if: you want the lowest-risk entry point (90-day money-back guarantee), prefer a provider with clean regulatory history, or want access to FDA-approved SLIT tablets for single-allergen treatment. Wyndly's 24/7 physician access and all-50-state coverage make it the most accessible option.

Choose Nectar if: clinical pedigree matters most to you, you have 1–2 dominant allergens (their focused high-concentration approach), and you're an adult comfortable with a newer company backed by $24M+ and top-tier clinical advisors.

Choose Quello if: you're in one of their ~21 covered states and want to start with a free allergy test to minimize upfront cost.

Choose HeyAllergy if: lowest price is your priority and you're comfortable with a provider with less public review data. ⚠️ Limited consumer feedback means less accountability evidence — not necessarily worse quality, but less information to evaluate.

Related Issues to Check

• Curex vs Wyndly comparison — Deep dive into the two largest providers: insurance billing, Trustpilot ratings, BBB records, FDA enforcement history, and which specific situations favor each.

• Curex vs Nectar allergy drops — Focused comparison of multi-allergen (Curex) vs high-concentration single-allergen (Nectar) approaches, clinical advisory teams, and pharmacy models.

• Are allergy drops FDA-approved? — All five providers' custom drops are off-label. Understanding FDA enforcement discretion, the distinction between drops and tablets, and what "off-label" actually means for safety and efficacy.

Frequently Asked Questions

Are any of these providers FDA-approved? No at-home provider's custom drops are FDA-approved. All compounded multi-allergen SLIT drops are prescribed off-label. Wyndly also prescribes FDA-approved single-allergen SLIT tablets (Grastek, Ragwitek, Odactra). Off-label prescribing is legal and common — over 20% of all US prescriptions are off-label — but it means less regulatory oversight of the specific formulations.

What about Allermi and Picnic — aren't they allergy treatment too? Allermi ($45/month) and Picnic ($12–20/month) are custom nasal spray subscriptions — combinations of antihistamines, steroids, and other symptom-control ingredients. They manage symptoms but do NOT modify your immune system. If you want your allergies to actually improve over time, you need immunotherapy, not a better nasal spray.

How do I know if a provider's compounding pharmacy is legitimate? Ask if their pharmacy has PCAB accreditation (Pharmacy Compounding Accreditation Board). Fewer than 1% of US compounding pharmacies (roughly 68 of 7,500+) hold this accreditation. The AMA recommends PCAB-accredited pharmacies for compounded medications.

Can I switch providers mid-treatment? Yes. All providers use sublingual drops with similar formulations. Switching doesn't require restarting from zero, though your new provider will review your allergen panel and may adjust your formula. Expect a brief overlap period.

How long does treatment take with any of these providers? All follow the standard immunotherapy timeline: 3–5 years for lasting tolerance. Most patients notice symptom improvement within 3–12 months, but stopping early (before 3 years) significantly reduces the chance of durable remission. About 20–30% of patients are non-responders regardless of provider (Gotoh 2017).

Which provider has the best outcomes? None publish proprietary outcomes data as of March 2026. All cite the broader SLIT evidence base (Tie 2022: comparable efficacy to shots across 46 RCTs). Until a provider publishes patient-level outcomes from their own cohort, claims of superiority are marketing, not evidence.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Find Your Best-Fit Provider in 3 Minutes

Your insurance, state, age, and allergen profile determine which provider saves you the most. A quick allergy quiz checks all four and shows personalized options.

Take the free 3-minute allergy quiz →